| 1 | though | 4,974 |
| 2 | albeit | 678 |
| 3 | multi-contact | 4 |
| 4 | derek | 3 |
| 5 | fvii-323 | 3 |
| 6 | rekindle | 3 |
| 7 | 'recurrent | 2 |
| 8 | 6011 | 2 |
| 9 | formule | 2 |
| 10 | nullifying | 2 |
| 11 | 16,426 | 1 |
| 12 | 20-times | 1 |
| 13 | 50,548 | 1 |
| 14 | 59/100.000 | 1 |
| 15 | 679enz | 1 |
| 16 | atypicality-or | 1 |
| 17 | b=flow | 1 |
| 18 | borderline-high-risk | 1 |
| 19 | carbapenems.recent | 1 |
| 20 | chemotherapy-promises | 1 |
| 21 | costs-effective | 1 |
| 22 | cries/screams | 1 |
| 23 | eliminated-when | 1 |
| 24 | etiology-directed | 1 |
| 25 | exposure-times | 1 |
| 26 | extracoporeal | 1 |
| 27 | gzt-treatment | 1 |
| 28 | haemathoxylon | 1 |
| 29 | haematoxylum | 1 |
| 30 | ii-tumors | 1 |
| 31 | interrogators | 1 |
| 32 | lung-to-lung | 1 |
| 33 | mf-c701 | 1 |
| 34 | microtraumatic | 1 |
| 35 | nanosight | 1 |
| 36 | playpen | 1 |
| 37 | proclaims | 1 |
| 38 | question-are | 1 |
| 39 | respectively.conclusions | 1 |
| 40 | sacramental | 1 |
| 41 | scantier | 1 |
| 42 | seminatural | 1 |
| 43 | serous-lined | 1 |
| 44 | synergistic-reductions | 1 |
| 45 | ten-watt-level | 1 |
| 46 | thoush | 1 |
| 47 | uv-pump/broadband-mid-ir-probe | 1 |
| 48 | worse.the | 1 |
| 1 | 'recurrent | 2 |
| 2 | 16,426 | 1 |
| 3 | 20-times | 1 |
| 4 | 50,548 | 1 |
| 5 | 59/100.000 | 1 |
| 6 | 6011 | 2 |
| 7 | 679enz | 1 |
| 8 | albeit | 678 |
| 9 | atypicality-or | 1 |
| 10 | b=flow | 1 |
| 11 | borderline-high-risk | 1 |
| 12 | carbapenems.recent | 1 |
| 13 | chemotherapy-promises | 1 |
| 14 | costs-effective | 1 |
| 15 | cries/screams | 1 |
| 16 | derek | 3 |
| 17 | eliminated-when | 1 |
| 18 | etiology-directed | 1 |
| 19 | exposure-times | 1 |
| 20 | extracoporeal | 1 |
| 21 | formule | 2 |
| 22 | fvii-323 | 3 |
| 23 | gzt-treatment | 1 |
| 24 | haemathoxylon | 1 |
| 25 | haematoxylum | 1 |
| 26 | ii-tumors | 1 |
| 27 | interrogators | 1 |
| 28 | lung-to-lung | 1 |
| 29 | mf-c701 | 1 |
| 30 | microtraumatic | 1 |
| 31 | multi-contact | 4 |
| 32 | nanosight | 1 |
| 33 | nullifying | 2 |
| 34 | playpen | 1 |
| 35 | proclaims | 1 |
| 36 | question-are | 1 |
| 37 | rekindle | 3 |
| 38 | respectively.conclusions | 1 |
| 39 | sacramental | 1 |
| 40 | scantier | 1 |
| 41 | seminatural | 1 |
| 42 | serous-lined | 1 |
| 43 | synergistic-reductions | 1 |
| 44 | ten-watt-level | 1 |
| 45 | though | 4,974 |
| 46 | thoush | 1 |
| 47 | uv-pump/broadband-mid-ir-probe | 1 |
| 48 | worse.the | 1 |
| 1 | 59/100.000 | 1 |
| 2 | mf-c701 | 1 |
| 3 | 6011 | 2 |
| 4 | fvii-323 | 3 |
| 5 | 16,426 | 1 |
| 6 | 50,548 | 1 |
| 7 | microtraumatic | 1 |
| 8 | serous-lined | 1 |
| 9 | etiology-directed | 1 |
| 10 | uv-pump/broadband-mid-ir-probe | 1 |
| 11 | worse.the | 1 |
| 12 | rekindle | 3 |
| 13 | formule | 2 |
| 14 | question-are | 1 |
| 15 | costs-effective | 1 |
| 16 | nullifying | 2 |
| 17 | lung-to-lung | 1 |
| 18 | though | 4,974 |
| 19 | thoush | 1 |
| 20 | derek | 3 |
| 21 | borderline-high-risk | 1 |
| 22 | extracoporeal | 1 |
| 23 | seminatural | 1 |
| 24 | sacramental | 1 |
| 25 | ten-watt-level | 1 |
| 26 | haematoxylum | 1 |
| 27 | eliminated-when | 1 |
| 28 | playpen | 1 |
| 29 | haemathoxylon | 1 |
| 30 | scantier | 1 |
| 31 | atypicality-or | 1 |
| 32 | 20-times | 1 |
| 33 | exposure-times | 1 |
| 34 | chemotherapy-promises | 1 |
| 35 | cries/screams | 1 |
| 36 | proclaims | 1 |
| 37 | respectively.conclusions | 1 |
| 38 | synergistic-reductions | 1 |
| 39 | ii-tumors | 1 |
| 40 | interrogators | 1 |
| 41 | multi-contact | 4 |
| 42 | nanosight | 1 |
| 43 | albeit | 678 |
| 44 | carbapenems.recent | 1 |
| 45 | gzt-treatment | 1 |
| 46 | 'recurrent | 2 |
| 47 | b=flow | 1 |
| 48 | 679enz | 1 |